You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 283 No. 10, March 8, 2000 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (115)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related articles
 •Similar articles in JAMA

Methadone Maintenance vs 180-Day Psychosocially Enriched Detoxification for Treatment of Opioid Dependence

A Randomized Controlled Trial

Karen L. Sees, DO; Kevin L. Delucchi, PhD; Carmen Masson, PhD; Amy Rosen, PsyD; H. Westley Clark, MD; Helen Robillard, RN, MSN, MA; Peter Banys, MD; Sharon M. Hall, PhD

JAMA. 2000;283:1303-1310.

Context  Despite evidence that methadone maintenance treatment (MMT) is effective for opioid dependence, it remains a controversial therapy because of its indefinite provision of a dependence-producing medication.

Objective  To compare outcomes of patients with opioid dependence treated with MMT vs an alternative treatment, psychosocially enriched 180-day methadone-assisted detoxification.

Design  Randomized controlled trial conducted from May 1995 to April 1999.

Setting  Research clinic in an established drug treatment service.

Patients  Of 858 volunteers screened, 179 adults with diagnosed opioid dependence were randomized into the study; 154 completed 12 weeks of follow-up.

Interventions  Patients were randomized to MMT (n = 91), which required 2 hours of psychosocial therapy per week during the first 6 months; or detoxification (n = 88), which required 3 hours of psychosocial therapy per week, 14 education sessions, and 1 hour of cocaine group therapy, if appropriate, for 6 months, and 6 months of (nonmethadone) aftercare services.

Main Outcome Measures  Treatment retention, heroin and cocaine abstinence (by self-report and monthly urinalysis), human immunodeficiency virus (HIV) risk behaviors (Risk of AIDS Behavior scale score), and function in 5 problem areas: employment, family, psychiatric, legal, and alcohol use (Addiction Severity Index), compared by intervention group.

Results  Methadone maintenance therapy resulted in greater treatment retention (median, 438.5 vs 174.0 days) and lower heroin use rates than did detoxification. Cocaine use was more closely related to study dropout in detoxification than in MMT. Methadone maintenance therapy resulted in a lower rate of drug-related (mean [SD] at 12 months, 2.17 [3.88] vs 3.73 [6.86]) but not sex-related HIV risk behaviors and in a lower severity score for legal status (mean [SD] at 12 months, 0.05 [0.13] vs 0.13 [0.19]). There were no differences between groups in employment or family functioning or alcohol use. In both groups, monthly heroin use rates were 50% or greater, but days of use per month dropped markedly from baseline.

Conclusions  Our results confirm the usefulness of MMT in reducing heroin use and HIV risk behaviors. Illicit opioid use continued in both groups, but frequency was reduced. Results do not provide support for diverting resources from MMT into long-term detoxification.


Author Affiliations: Department of Psychiatry, University of California, San Francisco (Drs Sees, Delucchi, Masson, Rosen, Clark, Banys, and Hall and Ms Robillard), and San Francisco Veterans Affairs Medical Center (Drs Sees and Banys).


RELATED LETTER

Methadone Maintenance for Opioid Dependence
William J. Annitto, Chris Kelly, Karen L. Sees, Kevin L. Delucchi, Carmen Masson, Amy Rosen, H. Westley Clark, Helen Robillard, Peter Banys, and Sharon M. Hall
JAMA. 2000;284(6):694-695.
EXTRACT | FULL TEXT  

RELATED ARTICLES

Treatment for Opioid Dependence: Quality and Access
Bruce J. Rounsaville and Thomas R. Kosten
JAMA. 2000;283(10):1337-1339.
EXTRACT | FULL TEXT  

Provision of Methadone Treatment in Primary Care Medical Practices: Review of the Scottish Experience and Implications for US Policy
Michael Weinrich and Mary Stuart
JAMA. 2000;283(10):1343-1348.
ABSTRACT | FULL TEXT  

March 8, 2000
JAMA. 2000;283(10):1361-1362.
EXTRACT | FULL TEXT  

Treating Drug Dependency
JAMA. 2000;283(10):1378.
PDF  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Using Buprenorphine for Outpatient Opioid Detoxification
Manlandro
JAOA: Journal of the American Osteopathic Association 2007;107:ES11-ES16.
ABSTRACT | FULL TEXT  

Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence.
Fiellin et al.
NEJM 2006;355:365-374.
ABSTRACT | FULL TEXT  

Heroin Detoxification--Reply
Collins et al.
JAMA 2006;295:886-886.
FULL TEXT  

Treatment of Heroin Dependence: Effectiveness, Costs, and Benefits of Methadone Maintenance
Schilling et al.
Research on Social Work Practice 2006;16:48-56.
ABSTRACT  

Methods of Detoxification and Their Role in Treating Patients With Opioid Dependence
O'Connor
JAMA 2005;294:961-963.
FULL TEXT  

Buprenorphine for Office-Based Treatment of Patients With Opioid Addiction
Manlandro
JAOA: Journal of the American Osteopathic Association 2005;105:S8-S13.
ABSTRACT | FULL TEXT  

Methods for Analysis of Skewed Data Distributions in Psychiatric Clinical Studies: Working With Many Zero Values
Delucchi and Bostrom
Am. J. Psychiatry 2004;161:1159-1168.
ABSTRACT | FULL TEXT  

Treating Opioid Dependence: Growing Implications for Primary Care
Krantz and Mehler
Arch Intern Med 2004;164:277-288.
ABSTRACT | FULL TEXT  

Management of Drug and Alcohol Withdrawal
Kosten and O'Connor
NEJM 2003;348:1786-1795.
FULL TEXT  

Substance-Related Disorders
Mack and Frances
Focus 2003;1:125-146.
ABSTRACT | FULL TEXT  

Clinical Trial Response and Dropout Rates with Olanzapine Versus Risperidone
Santarlasci and Messori
The Annals of Pharmacotherapy 2003;37:556-563.
ABSTRACT | FULL TEXT  

Bridging the Gap: A Hybrid Model to Link Efficacy and Effectiveness Research in Substance Abuse Treatment
Carroll and Rounsaville
Psychiatr. Serv. 2003;54:333-339.
ABSTRACT | FULL TEXT  

Office-Based Treatment of Opioid-Dependent Patients
Fiellin and O'Connor
NEJM 2002;347:817-823.
FULL TEXT  

Problems for clinical judgement: 5. Principles of influence in medical practice
Redelmeier and Cialdini
CMAJ 2002;166:1680-1684.
ABSTRACT | FULL TEXT  

Methadone Maintenance in Primary Care: A Randomized Controlled Trial
Fiellin et al.
JAMA 2001;286:1724-1731.
ABSTRACT | FULL TEXT  

Regular Outpatient Medical and Drug Abuse Care and Subsequent Hospitalization of Persons Who Use Illicit Drugs
Laine et al.
JAMA 2001;285:2355-2362.
ABSTRACT | FULL TEXT  

Liver Transplantation and Opioid Dependence
Koch and Banys
JAMA 2001;285:1056-1058.
ABSTRACT | FULL TEXT  

Treating Opioid Dependence -- New Data and New Opportunities
O'Connor
NEJM 2000;343:1332-1334.
FULL TEXT  

Methadone maintenance was more effective for treatment retention for opioid dependence than psychosocially enriched detoxification
Law
Evid. Based Med. 2000;5:180-180.
FULL TEXT  

Methadone Maintenance for Opioid Dependence
Annitto et al.
JAMA 2000;284:694-695.
FULL TEXT  

Methadone Maintenance: Is It Our Best Alternative?
JWatch Psychiatry 2000;2000:9-9.
FULL TEXT  

Treatment for Opioid Dependence: Quality and Access
Rounsaville and Kosten
JAMA 2000;283:1337-1339.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.